Moving Forward into the New Era of HSCT and Cellular Therapy
Today 2024.11.21 D-End
Today 
Moving Forward into the New Era of HSCT and Cellular Therapy
|
[OP01] Oral Presentation 1: ALL |
Room A | ||
|---|---|---|---|
| Date & Time | September 26 (Thu), 09:00-10:00 | ||
| Chair(s) |
Min Kyoung Kim (Yeungnam University College of Medicine, Korea) Ho Sup Lee (Kosin University College of Medicine, Korea) |
||
| Speaker(s) | 09:00-09:10 | Clinical Implication and Long-term Survival Outcome of Second Allogeneic HCT in Adult Patients with Relapsed Acute Lymphoblastic Leukemia before and after the Era of Novel Immunotherapeutic Agents Daehun Kwag (The Catholic University of Korea, Korea) | |
| 09:10-09:20 | Optimization of Pre-Transplant Conditioning for Haploidentical Donor Transplantation in Adult Acute Lymphoblastic Leukemia: Interim Phase 2 Results of TBI-Augmented Reduced Toxicity Regimen Incorporating ATG/PTC Jaehyun Ahn (The Catholic University of Korea, Korea) | ||
| 09:20-09:30 | Selection of Candidates for Allogenic Hematopoietic Stem Cell Transplantation with T-Lymphoblastic lymphoma by Comparative Study with T-Acute Lymphoblastic Leukemia Tong Yoon Kim (The Catholic University of Korea, Korea) | ||
| 09:30-09:40 | Optimization of TBI-Based Myeloablative Conditioning Regimen Incorporating ATG and PTCY in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation: Historical Comparison with TBI/CY Jongseo Lee (The Catholic University of Korea, Korea) | ||
| 09:40-09:50 | Korean Real-World Experience of Blinatumomab for 8 Years Regarding Predictive Factors Including Lymphocyte Kinetics for Response and Survival Outcome in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Seonghan Lee (The Catholic University of Korea, Korea) | ||
| 09:50-10:00 | Real-World Experiences of Inotuzumab Ozogamicin in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia Jae Ho Yoon (The Catholic University of Korea, Korea) | ||
|
[OP02] Oral Presentation 2: Multiple Myeloma |
Room B | ||
|---|---|---|---|
| Date & Time | September 26 (Thu), 09:00-10:00 | ||
| Chair(s) |
Jae Hoon Lee (Gachon University College of Medicine, Korea) Kihyun Kim (Sungkyunkwan University School of Medicine, Korea) |
||
| Speaker(s) | 09:00-09:10 | Impact of Tandem Autologous Stem Cell Transplantation in Multiple Myeloma Patients with MRD Positivity after First Transplantation, CARE-MM Study-2401 Sieun Oh (The Catholic University of Korea, Korea) | |
| 09:10-09:20 | CD4 Cytotoxic T Cells Promote Antitumor Immunity in Multiple Myeloma Sojeong Kim (Yonsei University College of Medicine, Korea) | ||
| 09:20-09:30 | Discoidin Domain Receptor 1 (DDR1) is Associated with Treatment Outcomes in Multiple Myeloma (MM) after Autologous Stem Cell Transplantation Ji-Young Lim (The Catholic University of Korea, Korea) | ||
| 09:30-09:40 | Mezigdomide plus Tazemetostat and Dexamethasone for Relapsed or Refractory Multiple Myeloma: Preliminary Results from the CA057-003 Trial Paul Richardson (Dana-Farber Cancer Institute, USA) | ||
| 09:40-09:50 | Evaluating the Efficacy and Safety of Immunotherapeutic T-Cell Engagers in Relapsed/Refractory Multiple Myeloma: A Real-World Comparison Data Analysis Mimicking RCT Sung-Soo Park (The Catholic University of Korea, Korea) | ||
| 09:50-10:00 | High B-cell Maturation Antigen Surface Expression on Myeloma Cells is Associated with Poor Survival Outcomes in Patients with Multiple Myeloma Suhyeon Hwang (Yonsei University College of Medicine, Korea) | ||
|
[OP03] Oral Presentation 3: AML |
Room C | ||
|---|---|---|---|
| Date & Time | September 26 (Thu), 09:00-10:00 | ||
| Chair(s) |
Inho Kim (Seoul National University College of Medicine, Korea) Seong Hyun Jeong (Ajou University School of Medicine, Korea) |
||
| Speaker(s) | 09:00-09:10 | Early Prediction of Hypomethylating Agent Based Therapy Outcome in Elderly Myeloid Disease Patients: A Geriatric Functional Assessment Approach Mihee Kim (Chonnam National University Medical School, Korea) | |
| 09:10-09:20 | Diagnostic NGS Panel-Based Serial Measurable Residual Disease Monitoring as a Prognostic Indicator in Acute Myeloid Leukemia Patients Jae-Sook Ahn (Chonnam National University Medical Schoo, Korea) | ||
| 09:20-09:30 | Role of Allogeneic Stem Cell Transplantation in FLT3-ITD Mutated AML Patients Treated with Midostaurin: A Comparative Analysis with Standard Chemotherapy Kyoung Il Min (The Catholic University of Korea, Korea) | ||
| 09:30-09:40 | Transplantation Outcomes after Venetoclax-Decitabine Compared to Conventional Chemotherapy as an Induction Therapy: A Propensity Score Matched Cohort Analysis Ka Young Kim (The Catholic University of Korea, Korea) | ||
| 09:40-09:50 | Phase I Study to Evaluate Safety of VT-Tri after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) Ki-Hyun Park (ViGenCell, Korea) | ||
| 09:50-10:00 | Post-Transplant Outcomes in FLT3-ITD Mutated Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Following Gilteritinib Treatment Daehun Kwag (The Catholic University of Korea, Korea) | ||
|
[OP04] Oral Presentation 4: Post-HCT Complications |
Room D | ||
|---|---|---|---|
| Date & Time | September 26 (Thu), 09:00-10:00 | ||
| Chair(s) |
Hyo Jung Kim (Hallym University College of Medicine, Korea) Yeon Jung Lim (Chungnam National University College of Medicine, Korea) |
||
| Speaker(s) | 09:00-09:10 | Risk Factors and Prognosis of Invasive Fungal Disease Following Hematopoietic Stem Cell Transplantation in 1076 Pediatric Patients Jiaming Yu (Shenzhen Children's Hospital, China) | |
| 09:10-09:20 | Korean Real-World Data of Defibrotide for Treatment of Adult Patients who Developed Severe Hepatic VOD/SOS after Allogeneic Hematopoietic Cell Transplantation Jae Ho Yoon (The Catholic University of Korea, Korea) | ||
| 09:20-09:30 | Mesenchymal Stem Cells Preconditioned with a TLR5 Agonist Enhanced Immunoregulatory Effect through M2 Macrophage Polarization in a Murine Graft-versus-Host Disease Model Junseok Lee (The Catholic University of Korea, Korea) | ||
| 09:30-09:40 | Efficacy and Safety of Defibrotide for Pediatric Veno-occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) - A Single Center Experience Shu-Wei Chou (National Taiwan University Hospital, Taiwan) | ||
| 09:40-09:50 | Aerosolized Pentamidine is an Effective Prophylaxis for Pneumocystis jiroveci Pneumonia in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation Ga-Young Song (Chonnam National University Medical School, Korea) | ||
| 09:50-10:00 | Exploring Risk Factors for Oral Mucositis in Lymphoma and Myeloma Patients Post-HSCT Ye Eun Oh (The Catholic University of Korea, Korea) | ||
|
[PL01] Plenary Session 1: State of the Art in Cellular Therapy & Immunotherapy September 26 (Thu), 10:40-12:00 |
Room A | |
|---|---|---|
| Chair(s) | Ki Woong Sung (Sungkyunkwan University School of Medicine, Korea) | |
Expanding Horizons of CAR T-Cell Therapy through Genome Editing
UCL Great Ormond Street Institute of Child Health, UK
Innovative Cellular Immunotherapy: Harnessing NK Cells, T Cells, and CAR-based Therapies for Cancer Treatment
Department of Companion and Laboratory Animal Science, Kongju National University, Korea
|
[LS01] Luncheon Symposium 1 (Johnson & Johnson): Diagnostic and Treatment Strategies for Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis September 26 (Thu), 12:10-12:50 |
Room A | |
|---|---|---|
| Chair(s) | Hyeon-Seok Eom (National Cancer Center, Korea) | |
Paving the Future of AL Amyloidosis Treatment with Daratumumab-Based Treatment
National and Kapodistrian University of Athens School of Medicine, Greece
|
[LS02] Luncheon Symposium 2 (Sanofi Aventis Korea) September 26 (Thu), 12:10-12:50 |
Room B | |
|---|---|---|
| Chair(s) | Sang Kyun Sohn (Kyungpook National University School of Medicine, Korea) | |
New Chapter of cGvHD Therapeutics: Belumosudil
Princess Margaret Cancer Centre, Canada
|
[LS03] Luncheon Symposium 3 (Gilead Science Korea Ltd.): Invasive Fungal Infection September 26 (Thu), 12:10-12:50 |
Room C | |
|---|---|---|
| Chair(s) | Sung-Hyun Kim (Dong-A University College of Medicine, Korea) | |
Invisible Invaders: All Things to Know about Fungal Infection in Hematology
Charité - Universitätsmedizin Berlin, Germany
|
[LS04] Luncheon Symposium 4 (Kyowa Kirin Korea): Efficacy and Safety of Romiplostim in First-Line Treatment of Severe Aplastic Anemia September 26 (Thu), 12:10-12:50 |
Room D-1 | |
|---|---|---|
| Chair(s) | Jong Wook Lee (Hanyang University Medical Center, Korea) | |
From Second-Line to First-line: The Evolving Role of Romiplostim in Severe Aplastic Anemia Management
Sungkyunkwan University School of Medicine, Korea
|
[LS05] Luncheon Symposium 5 (AbbVie Korea): Paradigm Shift of Unfit AML Patient Treatment with Venetoclax? September 26 (Thu), 12:10-12:50 |
Room D-2 | |
|---|---|---|
| Chair(s) | Hee-Je Kim (The Catholic University of Korea, Korea) | |
How I Manage of Unfit AML Patients with Venetoclax for Long-term Survival
Seoul National University College of Medicine, Korea
|
[PL02] Plenary Session 2: Recent Advances in Transplantation Research September 26 (Thu), 13:00-14:20 |
Room A | |
|---|---|---|
| Chair(s) | Jong Wook Lee (Hanyang University Medical Center, Korea) | |
Exploring the Influence of the Microbiome on Hematopoiesis and Immune Reconstitution
Fred Hutchinson Cancer Center, USA
Unraveling the Significance of Germline Predisposition Mutations in MDS prior to Transplantation
University College London Hospitals NHS Foundation Trust, UK
|
[JS01] Joint Symposium 1: ASTCT-KSBMT: Real-World Experiences and New Considerations of CAR-T Therapy in Lymphoid Malignancy September 26 (Thu), 14:30-16:00 |
Room A | |
|---|---|---|
| Chair(s) |
Je-Jung Lee (Chonnam National University Medical School, Korea) Stanley Riddell (Fred Hutchinson Cancer Center, USA) |
|
Strategies to Mitigate CAR T-Cell-Associated Cytokine Release Syndrome and Neurologic Toxicity
Fred Hutchinson Cancer Center, USA
Real-World Outcomes with CAR T-Cell Therapy for Lymphoid Malignancies
University of Chicago, USA
Real-World Data of CAR-T in Refractory Lymphoma in Korea
Sungkyunkwan University School of Medicine, Korea
|
[SS01] Scientific Session 1: Unraveling the Pathogenesis of Tissue Changes Post Transplantation September 26 (Thu), 14:30-16:00 |
Room B | |
|---|---|---|
| Chair(s) |
Sung-Soo Yoon (Seoul National University College of Medicine, Korea) Myung Geun Shin (Chonnam National University Medical School, Korea) |
|
Role of Tissue Niches in Acute GI-GVHD Revealed by Spatial Transcriptomics
Massachusetts General Hospital, USA
Endotheliopathies after Transplant and Immune Therapies in Hematologic Malignancy, with a Focus on the Evolving Role of Defibrotide, Including Its Potential in the Endotheliitis of COVID-19
Dana-Farber Cancer Institute, USA
Leukemia Immune Escape in Posttransplantation Relapses: From Biology to Personalized Medicine (And Back)
IRCCS San Raffaele Scientific Institute, Italy
|
[SS02] Scientific Session 2: Issues with Optimal Donor and Graft September 26 (Thu), 14:30-16:00 |
Room C | |
|---|---|---|
| Chair(s) |
Jong Ho Won (Soonchunhyang University College of Medicine, Korea) Ho Joon Im (University of Ulsan College of Medicine, Korea) |
|
The Optimization for T-Cell Replete Haploidentical Hematopoietic Stem Cell Transplantation
Peking University People's Hospital, China
PBSCT Using Posttransplant Cyclophosphamide from HLA-Matched and 1-2 Allele Mismatched Donor
Hokkaido University, Japan
Strategies to Enhance Graft Performance in Cord Blood Transplantation
The University of Tokyo, Japan
|
[ES01] Education Session 1: Expanding Transplant Outcomes Research Opportunities through AI September 26 (Thu), 14:30-16:00 |
Room D | |
|---|---|---|
| Chair(s) |
Ho-Jin Shin (Pusan National University School of Medicine, Korea) Byung Sik Cho (The Catholic University of Korea, Korea) |
|
Assisting Treatment Selection Based on Big Data and Machine Learning
Department of Chemical Engineering, Hongik University, Korea
Strategies for Integrating ChatGPT and Generative AI into Clinical Studies
Department of Surgery, Seoul National University College of Medicine, Korea
Machine Learning Applications in Hematopoietic Cell Transplantation
University of Ulsan College of Medicine, Korea
|
[JS02] Joint Symposium 2: JSTCT-KSBMT: Current Aging Landscape and Considerations for HSCT in the Elderly September 26 (Thu), 16:40-18:20 |
Room A | |
|---|---|---|
| Chair(s) |
Seong Kyu Park (Soonchunhyang University College of Medicine, Korea) Takanori Teshima (Hokkaido University, Japan) |
|
Aging Landscape and Pre-Transplantation Considerations for Elderly Patients in Japan
Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan
Transplantation Strategies and Outcome of Elderly Patients with Acute Leukemia in Japan
Toranomon Hospital, Japan
Geriatric Functional Assessments and Their Utility for Standard Intensive Chemotherapy and HSCT
The Catholic University of Korea, Korea
Transplantation Strategies and Outcome of Elderly Patients with Acute Leukemia in Korea
Kyungpook National University School of Medicine, Korea
|
[SS03] Scientific Session 3: HSCT and Cellular Therapies for Lymphoid Malignancies September 26 (Thu), 16:40-18:10 |
Room B | |
|---|---|---|
| Chair(s) |
Hoon Kook (Chonnam National University Medical School, Korea) Deok Hwan Yang (Chonnam National University Medical School, Korea) |
|
Choosing a CAR for Relapsed/Refractory DLBCL: Which CAR, for Whom, and When
Massachusetts General Hospital, Harvard Medical School, USA
Cellular Therapy for Primary and Secondary CNS Lymphoma: Transplantation? or CAR-T?
Sunnybrook Health Sciences Centre, Canada
Optimization of CAR-T Therapy for Acute Lymphoblastic Leukemia
Seoul National University College of Medicine, Korea
|
[SS04] Scientific Session 4: HCT in Bone Marrow Failure September 26 (Thu), 16:40-18:10 |
Room C | |
|---|---|---|
| Chair(s) |
Nack-Gyun Chung (The Catholic University of Korea, Korea) Seongsoo Jang (University of Ulsan College of Medicine, Korea) |
|
Interpretation of Germline Variants of IBMFS in Adult Patients with Hematologic Diseases
National Cancer Institute, USA
Hematopoietic Stem Cell Transplantation and Immunosuppressive Therapy in Aplastic Anemia
Jichi Medical University Saitama Medical Center, Japan
Genetic Diagnosis of Inherited Bone Marrow Failure Syndromes in the Era of Next-generation Sequencing
Sungkyunkwan University School of Medicine, Korea
|
[NS01] Nursing Session 1: Long-Term Follow-Up and Experience with Hematopoietic Stem Cell Transplant Patients I September 26 (Thu), 16:40-18:10 |
Room D | |
|---|---|---|
| Chair(s) | Minjin Choi (Samsung Medical Center, Korea) | |
Chasing after Blood Cancer for Forty Years
Konkuk University Medical Center, Korea
A 27-Year Journey as a Transplant Nurse "Empathy, Passion, and Resilience"
Asan Medical Center, Korea
A New Life Yet to Come: Twists and Turns in My Life as a Life Scientist and Cancer Patient
Department of Biological Sciences, KAIST, Korea
